<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font18 { font-size : 18; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">GRFT </span>
   <span class="font26">[]. </span>
   <span class="font18">HIV- </span>
   <span class="font17">antiviral </span>
   <span class="font15">binding </span>
   <span class="font15">cells </span>
   <span class="font15">HIV </span>
   <span class="font14">activity </span>
   <span class="font14">virus </span>
   <span class="font13">griffithsin </span>
   <span class="font13">viral </span>
   <span class="font13">carbohydrate-binding </span>
   <span class="font12">cell </span>
   <span class="font12">{border-style </span>
   <span class="font12">human </span>
   <span class="font12">px;} </span>
   <span class="font12">vitro </span>
   <span class="font12">vivo </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">infection </span>
   <span class="font12">protein </span>
   <span class="font12">sites </span>
   <span class="font11">anti-HIV </span>
   <span class="font11">lectin </span>
   <span class="font11">studies </span>
   <span class="font11">study </span>
   <span class="font11">target </span>
   <span class="font11">host </span>
   <span class="font11">potent </span>
   <span class="font11">DC-SIGN </span>
   <span class="font11">N/A </span>
   <span class="font11">glycosylation </span>
   <span class="font11">neutralization </span>
   <span class="font11">GRFT, </span>
   <span class="font11">TZM-bl </span>
   <span class="font11">entry </span>
   <span class="font11">mannose </span>
   <span class="font11">mice </span>
   <span class="font11">resistance </span>
   <span class="font11">addition, </span>
   <span class="font11">production </span>
   <span class="font11">transmission </span>
   <span class="font11">using </span>
   <span class="font11">vaginal </span>
   <span class="font11">However, </span>
   <span class="font11">dimer </span>
   <span class="font11">efficacy </span>
   <span class="font11">isolates </span>
   <span class="font11">proteins </span>
   <span class="font11">toxicity </span>
   <span class="font11">viruses </span>
   <span class="font11">(Table </span>
   <span class="font11">GRFT. </span>
   <span class="font11">Ref. </span>
   <span class="font11">Table </span>
   <span class="font11">amino </span>
   <span class="font11">clinical </span>
   <span class="font11">marinedrugs---t_Table </span>
   <span class="font11">mechanism </span>
   <span class="font11">microbicide </span>
   <span class="font11">potential </span>
   <span class="font11">results </span>
   <span class="font11">showed </span>
   <span class="font11">subtype </span>
   <span class="font11">synergistic </span>
   <span class="font11">HSV- </span>
   <span class="font11">Nicotiana </span>
   <span class="font11">[], </span>
   <span class="font11">ability </span>
   <span class="font11">anti-HIV- </span>
   <span class="font11">combination </span>
   <span class="font11">different </span>
   <span class="font11">drug </span>
   <span class="font11">effect </span>
   <span class="font11">effects </span>
   <span class="font11">enveloped </span>
   <span class="font11">inhibited </span>
   <span class="font11">new </span>
   <span class="font11">px; </span>
   <span class="font11">release </span>
   <span class="font11">site </span>
   <span class="font11">{font-family </span>
   <span class="font10">Agents </span>
   <span class="font10">PBMC </span>
   <span class="font10">cells, </span>
   <span class="font10">delivery </span>
   <span class="font10">development </span>
   <span class="font10">font-size </span>
   <span class="font10">fusion </span>
   <span class="font10">immunodeficiency </span>
   <span class="font10">interaction </span>
   <span class="font10">position </span>
   <span class="font10">primary </span>
   <span class="font10">reported </span>
   <span class="font10">safety </span>
   <span class="font10">structure </span>
   <span class="font10">treatment </span>
   <span class="font10">CCR-tropic </span>
   <span class="font10">Chemother../AAC.- </span>
   <span class="font10">HCV </span>
   <span class="font10">Synergy </span>
   <span class="font10">able </span>
   <span class="font10">action </span>
   <span class="font10">administered </span>
   <span class="font10">animal </span>
   <span class="font10">antiretroviral </span>
   <span class="font10">assay </span>
   <span class="font10">changes </span>
   <span class="font10">clade </span>
   <span class="font10">demonstrated </span>
   <span class="font10">dose </span>
   <span class="font10">double; </span>
   <span class="font10">envelope </span>
   <span class="font10">glycan </span>
   <span class="font10">glycans </span>
   <span class="font10">glycoproteins </span>
   <span class="font10">griffithsin, </span>
   <span class="font10">high-mannose </span>
   <span class="font10">indicates </span>
   <span class="font10">inhibitor </span>
   <span class="font10">mg/kg </span>
   <span class="font10">positions </span>
   <span class="font10">potency </span>
   <span class="font10">profiles </span>
   <span class="font10">receptor </span>
   <span class="font10">recombinant </span>
   <span class="font10">red </span>
   <span class="font10">single </span>
   <span class="font10">strain </span>
   <span class="font10">structural </span>
   <span class="font10">therapeutic </span>
   <span class="font10">transfer </span>
   <span class="font10">type </span>
   <span class="font10">DC-SIGN-mediated </span>
   <span class="font10">ONEe./journal.pone. </span>
   <span class="font10">Raji/DC-SIGN </span>
   <span class="font10">acid </span>
   <span class="font10">acids </span>
   <span class="font10">blood </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">capture </span>
   <span class="font10">cyanovirin-n </span>
   <span class="font10">endosperm </span>
   <span class="font10">extract </span>
   <span class="font10">form </span>
   <span class="font10">gel </span>
   <span class="font10">immune </span>
   <span class="font10">increase </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibition </span>
   <span class="font10">multivalent </span>
   <span class="font10">novel </span>
   <span class="font10">oligosaccharides </span>
   <span class="font10">peptide </span>
   <span class="font10">pharmacokinetic </span>
   <span class="font10">placebo </span>
   <span class="font10">plants </span>
   <span class="font10">present </span>
   <span class="font10">protected </span>
   <span class="font10">provide </span>
   <span class="font10">response </span>
   <span class="font10">rhamnosus </span>
   <span class="font10">rice </span>
   <span class="font10">role </span>
   <span class="font10">similar </span>
   <span class="font10">solid; </span>
   <span class="font10">soluble </span>
   <span class="font10">strains </span>
   <span class="font10">subcutaneous </span>
   <span class="font10">suggests </span>
   <span class="font10">tobacco </span>
   <span class="font10">use </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Figure </span>
   <span class="font10">Anti-HIV- </span>
   <span class="font10">DC-SIGN-dependent </span>
   <span class="font10">Drug </span>
   <span class="font10">Effects </span>
   <span class="font10">FDI </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">GRFT-mediated </span>
   <span class="font10">HIV-, </span>
   <span class="font10">HPV </span>
   <span class="font10">JEV </span>
   <span class="font10">Loss </span>
   <span class="font10">N-acetyl </span>
   <span class="font10">PBMCs </span>
   <span class="font10">Single </span>
   <span class="font10">[,]; </span>
   <span class="font10">activation </span>
   <span class="font10">activity, </span>
   <span class="font10">administration </span>
   <span class="font10">antibody </span>
   <span class="font10">associated </span>
   <span class="font10">benthamiana </span>
   <span class="font10">bold </span>
   <span class="font10">bound </span>
   <span class="font10">carrageenan </span>
   <span class="font10">caused </span>
   <span class="font10">cell-cell </span>
   <span class="font10">cervical </span>
   <span class="font10">concentrations </span>
   <span class="font10">courier; </span>
   <span class="font10">crescentus </span>
   <span class="font10">death </span>
   <span class="font10">displayed </span>
   <span class="font10">drugs </span>
   <span class="font10">efficient </span>
   <span class="font10">em; </span>
   <span class="font10">enhanced </span>
   <span class="font10">expressed </span>
   <span class="font10">expressing </span>
   <span class="font10">extracts </span>
   <span class="font10">fibers </span>
   <span class="font10">formation </span>
   <span class="font10">glucose </span>
   <span class="font10">glycosylated </span>
   <span class="font10">gp, </span>
   <span class="font10">gp-binding </span>
   <span class="font10">herpes </span>
   <span class="font10">including </span>
   <span class="font10">infections </span>
   <span class="font10">initial </span>
   <span class="font10">interactions </span>
   <span class="font10">intravaginal </span>
   <span class="font10">large-scale </span>
   <span class="font10">lectins </span>
   <span class="font10">mAb, </span>
   <span class="font10">mGRFT </span>
   <span class="font10">microbicides </span>
   <span class="font10">minimal </span>
   <span class="font10">mode </span>
   <span class="font10">model </span>
   <span class="font10">molecules </span>
   <span class="font10">monomer </span>
   <span class="font10">monomeric </span>
   <span class="font10">mucosal </span>
   <span class="font10">mutations </span>
   <span class="font10">neutralizing </span>
   <span class="font10">observed </span>
   <span class="font10">ongoing </span>
   <span class="font10">patterns </span>
   <span class="font10">phase </span>
   <span class="font10">phase-one </span>
   <span class="font10">prevent </span>
   <span class="font10">prevention </span>
   <span class="font10">preventive </span>
   <span class="font10">produced </span>
   <span class="font10">proteome </span>
   <span class="font10">pt;} </span>
   <span class="font10">rectal </span>
   <span class="font10">residues </span>
   <span class="font10">sensitivity </span>
   <span class="font10">studied </span>
   <span class="font10">superior </span>
   <span class="font10">therapeutics </span>
   <span class="font10">topical </span>
   <span class="font10">unique </span>
   <span class="font10">used </span>
   <span class="font10">various </span>
  </p>
 </body>
</html>
